The FemTech Series: Analysing the risk of breast cancer recurrence
In this episode of The FemTech Series, you can hear Olivia Friett, editor of Medical Plastics News talk to Hemmel Amrania PhD, CEO of Digistain, a company that has won multiple awards for its transformative breast cancer biomarker analytics.
The FemTech Series: Analysing the risk of breast cancer recurrence
In this episode of The FemTech Series, you can hear Olivia Friett, editor of Medical Plastics News talk to Hemmel Amrania PhD, CEO of Digistain, a company that has won multiple awards for its transformative breast cancer biomarker analytics.